The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preclinical Imaging (In-VIVO) Market Research Report 2025
Synopsis
The global Preclinical Imaging (In-VIVO) market was valued at US$ 679.7 million in 2023 and is anticipated to reach US$ 892.3 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
North American market for Preclinical Imaging (In-VIVO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preclinical Imaging (In-VIVO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preclinical Imaging (In-VIVO) in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preclinical Imaging (In-VIVO) include PerkinElmer, Bruker Corporation, FUJIFILM Holdings, Mediso, MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences and Trifoil Imaging, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preclinical Imaging (In-VIVO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Imaging (In-VIVO).
Report Scope
The Preclinical Imaging (In-VIVO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Imaging (In-VIVO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Imaging (In-VIVO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PerkinElmer
Bruker Corporation
FUJIFILM Holdings
Mediso
MILabs B.V.
MR Solutions
Aspect Imaging
LI-COR Biosciences
Trifoil Imaging
Miltenyi Biotec
Segment by Type
Equipment
Reagent
Segment by Application
Oncology
Cardio and Vascular
Neurology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Imaging (In-VIVO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Preclinical Imaging (In-VIVO) market was valued at US$ 679.7 million in 2023 and is anticipated to reach US$ 892.3 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
North American market for Preclinical Imaging (In-VIVO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preclinical Imaging (In-VIVO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preclinical Imaging (In-VIVO) in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preclinical Imaging (In-VIVO) include PerkinElmer, Bruker Corporation, FUJIFILM Holdings, Mediso, MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences and Trifoil Imaging, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preclinical Imaging (In-VIVO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Imaging (In-VIVO).
Report Scope
The Preclinical Imaging (In-VIVO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Imaging (In-VIVO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Imaging (In-VIVO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PerkinElmer
Bruker Corporation
FUJIFILM Holdings
Mediso
MILabs B.V.
MR Solutions
Aspect Imaging
LI-COR Biosciences
Trifoil Imaging
Miltenyi Biotec
Segment by Type
Equipment
Reagent
Segment by Application
Oncology
Cardio and Vascular
Neurology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Imaging (In-VIVO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Imaging (In-VIVO) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment
1.2.3 Reagent
1.3 Market by Application
1.3.1 Global Preclinical Imaging (In-VIVO) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardio and Vascular
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Imaging (In-VIVO) Market Perspective (2019-2030)
2.2 Preclinical Imaging (In-VIVO) Growth Trends by Region
2.2.1 Global Preclinical Imaging (In-VIVO) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preclinical Imaging (In-VIVO) Historic Market Size by Region (2019-2024)
2.2.3 Preclinical Imaging (In-VIVO) Forecasted Market Size by Region (2025-2030)
2.3 Preclinical Imaging (In-VIVO) Market Dynamics
2.3.1 Preclinical Imaging (In-VIVO) Industry Trends
2.3.2 Preclinical Imaging (In-VIVO) Market Drivers
2.3.3 Preclinical Imaging (In-VIVO) Market Challenges
2.3.4 Preclinical Imaging (In-VIVO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Imaging (In-VIVO) Players by Revenue
3.1.1 Global Top Preclinical Imaging (In-VIVO) Players by Revenue (2019-2024)
3.1.2 Global Preclinical Imaging (In-VIVO) Revenue Market Share by Players (2019-2024)
3.2 Global Preclinical Imaging (In-VIVO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical Imaging (In-VIVO) Revenue
3.4 Global Preclinical Imaging (In-VIVO) Market Concentration Ratio
3.4.1 Global Preclinical Imaging (In-VIVO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Imaging (In-VIVO) Revenue in 2023
3.5 Preclinical Imaging (In-VIVO) Key Players Head office and Area Served
3.6 Key Players Preclinical Imaging (In-VIVO) Product Solution and Service
3.7 Date of Enter into Preclinical Imaging (In-VIVO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Imaging (In-VIVO) Breakdown Data by Type
4.1 Global Preclinical Imaging (In-VIVO) Historic Market Size by Type (2019-2024)
4.2 Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Type (2025-2030)
5 Preclinical Imaging (In-VIVO) Breakdown Data by Application
5.1 Global Preclinical Imaging (In-VIVO) Historic Market Size by Application (2019-2024)
5.2 Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preclinical Imaging (In-VIVO) Market Size (2019-2030)
6.2 North America Preclinical Imaging (In-VIVO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preclinical Imaging (In-VIVO) Market Size by Country (2019-2024)
6.4 North America Preclinical Imaging (In-VIVO) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Imaging (In-VIVO) Market Size (2019-2030)
7.2 Europe Preclinical Imaging (In-VIVO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preclinical Imaging (In-VIVO) Market Size by Country (2019-2024)
7.4 Europe Preclinical Imaging (In-VIVO) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size (2019-2030)
8.2 Asia-Pacific Preclinical Imaging (In-VIVO) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2019-2024)
8.4 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Imaging (In-VIVO) Market Size (2019-2030)
9.2 Latin America Preclinical Imaging (In-VIVO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2019-2024)
9.4 Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size (2019-2030)
10.2 Middle East & Africa Preclinical Imaging (In-VIVO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2019-2024)
10.4 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Detail
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer Preclinical Imaging (In-VIVO) Introduction
11.1.4 PerkinElmer Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.1.5 PerkinElmer Recent Development
11.2 Bruker Corporation
11.2.1 Bruker Corporation Company Detail
11.2.2 Bruker Corporation Business Overview
11.2.3 Bruker Corporation Preclinical Imaging (In-VIVO) Introduction
11.2.4 Bruker Corporation Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.2.5 Bruker Corporation Recent Development
11.3 FUJIFILM Holdings
11.3.1 FUJIFILM Holdings Company Detail
11.3.2 FUJIFILM Holdings Business Overview
11.3.3 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Introduction
11.3.4 FUJIFILM Holdings Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.3.5 FUJIFILM Holdings Recent Development
11.4 Mediso
11.4.1 Mediso Company Detail
11.4.2 Mediso Business Overview
11.4.3 Mediso Preclinical Imaging (In-VIVO) Introduction
11.4.4 Mediso Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.4.5 Mediso Recent Development
11.5 MILabs B.V.
11.5.1 MILabs B.V. Company Detail
11.5.2 MILabs B.V. Business Overview
11.5.3 MILabs B.V. Preclinical Imaging (In-VIVO) Introduction
11.5.4 MILabs B.V. Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.5.5 MILabs B.V. Recent Development
11.6 MR Solutions
11.6.1 MR Solutions Company Detail
11.6.2 MR Solutions Business Overview
11.6.3 MR Solutions Preclinical Imaging (In-VIVO) Introduction
11.6.4 MR Solutions Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.6.5 MR Solutions Recent Development
11.7 Aspect Imaging
11.7.1 Aspect Imaging Company Detail
11.7.2 Aspect Imaging Business Overview
11.7.3 Aspect Imaging Preclinical Imaging (In-VIVO) Introduction
11.7.4 Aspect Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.7.5 Aspect Imaging Recent Development
11.8 LI-COR Biosciences
11.8.1 LI-COR Biosciences Company Detail
11.8.2 LI-COR Biosciences Business Overview
11.8.3 LI-COR Biosciences Preclinical Imaging (In-VIVO) Introduction
11.8.4 LI-COR Biosciences Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.8.5 LI-COR Biosciences Recent Development
11.9 Trifoil Imaging
11.9.1 Trifoil Imaging Company Detail
11.9.2 Trifoil Imaging Business Overview
11.9.3 Trifoil Imaging Preclinical Imaging (In-VIVO) Introduction
11.9.4 Trifoil Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.9.5 Trifoil Imaging Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Detail
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Preclinical Imaging (In-VIVO) Introduction
11.10.4 Miltenyi Biotec Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024)
11.10.5 Miltenyi Biotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Preclinical Imaging (In-VIVO) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Equipment
Table 3. Key Players of Reagent
Table 4. Global Preclinical Imaging (In-VIVO) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Preclinical Imaging (In-VIVO) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Preclinical Imaging (In-VIVO) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Preclinical Imaging (In-VIVO) Market Share by Region (2019-2024)
Table 8. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Preclinical Imaging (In-VIVO) Market Share by Region (2025-2030)
Table 10. Preclinical Imaging (In-VIVO) Market Trends
Table 11. Preclinical Imaging (In-VIVO) Market Drivers
Table 12. Preclinical Imaging (In-VIVO) Market Challenges
Table 13. Preclinical Imaging (In-VIVO) Market Restraints
Table 14. Global Preclinical Imaging (In-VIVO) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Preclinical Imaging (In-VIVO) Market Share by Players (2019-2024)
Table 16. Global Top Preclinical Imaging (In-VIVO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Imaging (In-VIVO) as of 2023)
Table 17. Ranking of Global Top Preclinical Imaging (In-VIVO) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Preclinical Imaging (In-VIVO) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Preclinical Imaging (In-VIVO) Product Solution and Service
Table 21. Date of Enter into Preclinical Imaging (In-VIVO) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Preclinical Imaging (In-VIVO) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type (2019-2024)
Table 25. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type (2025-2030)
Table 27. Global Preclinical Imaging (In-VIVO) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Application (2019-2024)
Table 29. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Application (2025-2030)
Table 31. North America Preclinical Imaging (In-VIVO) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Preclinical Imaging (In-VIVO) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Preclinical Imaging (In-VIVO) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Preclinical Imaging (In-VIVO) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Preclinical Imaging (In-VIVO) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Preclinical Imaging (In-VIVO) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Preclinical Imaging (In-VIVO) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2025-2030) & (US$ Million)
Table 46. PerkinElmer Company Detail
Table 47. PerkinElmer Business Overview
Table 48. PerkinElmer Preclinical Imaging (In-VIVO) Product
Table 49. PerkinElmer Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 50. PerkinElmer Recent Development
Table 51. Bruker Corporation Company Detail
Table 52. Bruker Corporation Business Overview
Table 53. Bruker Corporation Preclinical Imaging (In-VIVO) Product
Table 54. Bruker Corporation Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 55. Bruker Corporation Recent Development
Table 56. FUJIFILM Holdings Company Detail
Table 57. FUJIFILM Holdings Business Overview
Table 58. FUJIFILM Holdings Preclinical Imaging (In-VIVO) Product
Table 59. FUJIFILM Holdings Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 60. FUJIFILM Holdings Recent Development
Table 61. Mediso Company Detail
Table 62. Mediso Business Overview
Table 63. Mediso Preclinical Imaging (In-VIVO) Product
Table 64. Mediso Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 65. Mediso Recent Development
Table 66. MILabs B.V. Company Detail
Table 67. MILabs B.V. Business Overview
Table 68. MILabs B.V. Preclinical Imaging (In-VIVO) Product
Table 69. MILabs B.V. Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 70. MILabs B.V. Recent Development
Table 71. MR Solutions Company Detail
Table 72. MR Solutions Business Overview
Table 73. MR Solutions Preclinical Imaging (In-VIVO) Product
Table 74. MR Solutions Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 75. MR Solutions Recent Development
Table 76. Aspect Imaging Company Detail
Table 77. Aspect Imaging Business Overview
Table 78. Aspect Imaging Preclinical Imaging (In-VIVO) Product
Table 79. Aspect Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 80. Aspect Imaging Recent Development
Table 81. LI-COR Biosciences Company Detail
Table 82. LI-COR Biosciences Business Overview
Table 83. LI-COR Biosciences Preclinical Imaging (In-VIVO) Product
Table 84. LI-COR Biosciences Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 85. LI-COR Biosciences Recent Development
Table 86. Trifoil Imaging Company Detail
Table 87. Trifoil Imaging Business Overview
Table 88. Trifoil Imaging Preclinical Imaging (In-VIVO) Product
Table 89. Trifoil Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 90. Trifoil Imaging Recent Development
Table 91. Miltenyi Biotec Company Detail
Table 92. Miltenyi Biotec Business Overview
Table 93. Miltenyi Biotec Preclinical Imaging (In-VIVO) Product
Table 94. Miltenyi Biotec Revenue in Preclinical Imaging (In-VIVO) Business (2019-2024) & (US$ Million)
Table 95. Miltenyi Biotec Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical Imaging (In-VIVO) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Preclinical Imaging (In-VIVO) Market Share by Type: 2023 VS 2030
Figure 3. Equipment Features
Figure 4. Reagent Features
Figure 5. Global Preclinical Imaging (In-VIVO) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Preclinical Imaging (In-VIVO) Market Share by Application: 2023 VS 2030
Figure 7. Oncology Case Studies
Figure 8. Cardio and Vascular Case Studies
Figure 9. Neurology Case Studies
Figure 10. Others Case Studies
Figure 11. Preclinical Imaging (In-VIVO) Report Years Considered
Figure 12. Global Preclinical Imaging (In-VIVO) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Preclinical Imaging (In-VIVO) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Preclinical Imaging (In-VIVO) Market Share by Region: 2023 VS 2030
Figure 15. Global Preclinical Imaging (In-VIVO) Market Share by Players in 2023
Figure 16. Global Top Preclinical Imaging (In-VIVO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Imaging (In-VIVO) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Preclinical Imaging (In-VIVO) Revenue in 2023
Figure 18. North America Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Preclinical Imaging (In-VIVO) Market Share by Country (2019-2030)
Figure 20. United States Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Preclinical Imaging (In-VIVO) Market Share by Country (2019-2030)
Figure 24. Germany Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Preclinical Imaging (In-VIVO) Market Share by Region (2019-2030)
Figure 32. China Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Preclinical Imaging (In-VIVO) Market Share by Country (2019-2030)
Figure 40. Mexico Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Preclinical Imaging (In-VIVO) Market Share by Country (2019-2030)
Figure 44. Turkey Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. PerkinElmer Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 47. Bruker Corporation Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 48. FUJIFILM Holdings Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 49. Mediso Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 50. MILabs B.V. Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 51. MR Solutions Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 52. Aspect Imaging Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 53. LI-COR Biosciences Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 54. Trifoil Imaging Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 55. Miltenyi Biotec Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
